Current knowledge of Japanese type 1 diabetic syndrome

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue 5, 2002, Pages 357-366

  Abiru, Norio ^a   Kawasaki, Eiji ^a   Eguch, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Autoantibodies; Genetics; Japanese; Prediction; Type 1 diabetes

Indexed keywords

AUTOANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 2; INSULIN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VITAMIN D RECEPTOR;

ADULT; ALLELE; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE IDENTIFICATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MALE; MOUSE; NONHUMAN; PANCREAS SECRETION; PANCREATITIS; PHENOTYPE; POPULATION RESEARCH; PREDICTION AND FORECASTING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; VARIABLE NUMBER OF TANDEM REPEAT;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; GENES, MHC CLASS II; HUMANS; IMMUNOCONJUGATES; INCIDENCE; INSULIN; JAPAN; MAJOR HISTOCOMPATIBILITY COMPLEX; SYNDROME;

EID: 0036709940     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.323     Document Type: Review

References (93)

1. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
2. Abiru N, Eisenbarth GS. Multiple genes/multiple autoantigens. Clin Rev Allergy Immunol 2000; 18: 27-40.
3. Kawasaki E, Eisenbarth G. High-throughput radioassays for autoantibodies to recombinant autoantigens. Frontiers Biosci 2000; 181-190.
4. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. Osaka IDDM Study Group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 2000; 342: 301-307.
5. Karvonen M, Tuomilehto J, Libman I, LaPorte R. WHO DIAMOND Project Group. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 883-892.
6. Kida K, Mimura G, Ito T, Murakami K, Ashkenazi I, Laron Z. The Data Committee for Childhood Diabetes of the Japan Diabetes Society (JDS). Incidence of type 1 diabetes mellitus in children aged 0-14 in Japan, 1986-1990, including an analysis for seasonality of onset and month of birth: JDS study. Diabetes Med 2000; 17: 59-63.
7. Ikegami H, Ogihara T. Genetics of insulin-dependent diabetes mellitus. Endocr J 1996; 43: 605-613.
8. Drykoningen CEM, Mulder ALM, Vaandrager GJ, LaPorte RE, Bruining GJ. The incidence of male childhood type 1 (insulin-dependent) diabetes mellitus is rising rapidly in the Netherlands. Diabetologia 1992; 35: 139-142.
9. Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EAM. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. BMJ 1997; 315: 713-717.
10. Matsuura N, Fukuda K, Okuno A, et al. Descriptive epidemiology of IDDM in Hokkaido, Japan: the childhood IDDM Hokkaido. Registry Diabetes Care 1998; 21: 1632-1636.
11. Borch-Johnsen K, Joner G, Mandrup-Poulsen T, et al. Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A Hypothesis Lancet 1984; 2: 1083-1086.
12. Zimmet PZ, Tuomi T, Mackay IR, et al. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetes Med 1994; 11: 299-303.
13. Abiru N, Takino H, Yano M, et al. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. J Autoimmun 1996; 9: 683-688.
14. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles WJ, Mackay IR. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes in adults with a non-insulin-dependent onset of diabetes. Diabetes 1993; 42: 359-362.
15. Park Y, Lee H, Koh CS, et al. The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients. Diabetes Care 1996; 19: 241-245.
16. Banerji MA, Chaiken RL, Huey H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Diabetes 1994; 43: 741-745.
17. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P. Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care 2001; 24: 1014-1018.
18. Kawasaki E, Sera Y, Yamakawa K, et al. Identification and functional analysis of mutations in the hepatocyte nuclear factor-1alpha gene in anti-islet autoantibody-negative Japanese patients with type 1 diabetes. J Clin Endocrinol Metab 2000; 85: 331-335.
19. Moller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O. Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having type 1 diabetes. Diabetologia 1998; 41: 1528-1531.
20. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995; 346: 1458-1463.
21. Inoue H, Tanizawa Y, Wasson J, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 1998; 20: 143-148.
22. Strom TM, Hortnagel K, Hofmann S, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998; 7: 2021-2028.
23. Awata T, Inoue K, Kurihara S, et al. Missense variations of the gene responsible for Wolfram syndrome (WFS1/wolframin) in Japanese: possible contribution of the Arg456His mutation to type 1 diabetes as a nonautoimmune genetic basis. Biochem Biophys Res Commun 2000; 268: 612-616.
24. Lernmark Å, Ott J. Sometimes it's hot, sometimes it's not. Nat Genet 1998; 19(213): 214.
25. Concannon P, Gogolin-Ewens KJ, Hinds DA, et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998; 19: 292-296.
26. Mein CA, Esposito L, Dunn MG, et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998; 19: 297-300.
27. Awata T, Kuzuya T, Matsuda A, Iwamoto Y, Kanazawa Y. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1992; 35: 419-424.
28. Hashimoto M, Kinoshita T, Yamasaki M, et al. Gene frequencies and haplotypic associations within the HLA region in 916 unrelated Japanese individuals. Tissue Antigens 1994; 44: 166-173.
29. Kawasaki E, Noble J, Erlich H, Mulgrew CL, Fain PR, Eisenbarth GS. Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes 1998; 47: 1971-1973.
30. Kawabata Y, Ikegami H, Kawaguchi Y, et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 2002; 51: 545-551.
31. Nishimaki K, Kawamura T, Inada H, et al. HLA DPB1*0201 gene confers disease susceptibility in Japanese with childhood onset type I diabetes, independent of HLA-DR and DQ genotypes. Diabetes Res Clin Pract 2000; 47: 49-55.
32. Nakanishi K, Kobayashi T, Murase T, et al. Association of HLA-A24 with complete β-cell destruction in IDDM. Diabetes 1993; 42: 1086-1098.
33. Nakanishi K, Kobayashi T, Murase T, Naruse T, Nose Y, Inoko H. Human leukocyte antigen-A24 and -DQA1*0301 in Japanese insulin-dependent diabetes mellitus: independent contributions to susceptibility to the disease and additive contributions to acceleration of beta-cell destruction. J Clin Endocrinol Metab 1999; 84: 3721-3725.
34. Awata T, Shibasaki Y, Hirai H, Okabe T, Kanazawa Y, Takaku F. Restriction fragment length polymorphism of the insulin gene region in Japanese diabetic and non-diabetic subjects. Diabetologia 1985; 28: 911-913.
35. Takeda J, Seino Y, Fukumoto H, et al. The polymorphism linked to the human insulin gene: its lack of association with either IDDM or NIDDM in Japanese. Acta Endocrinol (Copenhagen) 1986; 113: 268-271.
36. Awata T, Kurihara S, Kikuchi C, et al. Evidence for association between the class I subset of the insulin gene minisatellite (IDDM2 locus) and IDDM in the Japanese population. Diabetes 1997; 46: 1637-1642.
37. Nishino M, Ikegami H, Kawaguchi Y, et al. Polymorphism in gene for islet autoantigen, IA-2, and type 1 diabetes in Japanese subjects. Hum Immunol 2001; 62: 518-522.
38. Ihara K, Ahmed S, Nakao F, et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 2001; 53: 447-454.
39. Ban Y, Taniyama M, Tozaki T, et al. No association of type 1 diabetes with a microsatellite marker for CTLA- 4 in a Japanese population. Autoimmunity 2001; 34: 39-43.
40. Awata T, Kurihara S, Iitaka M, et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 1998; 47: 128, 129.
41. Abe T, Yamaguchi Y, Takino H, et al. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody. Diabetes Med 2001; 18: 726-731.
42. Abe T, Takino H, Yamasaki H, et al. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res Clin Pract 1999; 46: 169-175.
43. Iwata I, Nagafuchi S, Nakashima H, et al. Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese. Diabetes 1999; 48: 416-419.
44. Ban Y, Taniyama M, Yanagawa T, et al. Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet 2001; 2: 7.
45. Ide A, Kawasaki E, Abiru N, et al. Genetic association between Interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum Immunol 2002; 63: 690-695.
46. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984; 33: 176-183.
47. Bennett ST, Lucassen AM, Gough SCL, et al. Susceptibility to human type I diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284-292.
48. Copeman JB, Cucca F, Hearne CM, et al. Linkage disequilibrium mapping of type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33. Nat Genet 1995; 9: 80-85.
49. Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 1996; 272: 1811-1813.
50. van den Maagdenberg AM, Olde WD, Rijss J, et al. Assignment of the human gene for receptor-type protein tyrosine phosphatase IA-2 (PTPRN) to chromosome region 2q35->q36.1 and identification of an intragenic genetic marker. Cytogenet Cell Genet 1996; 73: 145-148.
51. Marron MP, Raffel LJ, Garchon HJ, et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997; 6: 1275-1282.
52. Ota M, Katsuyama Y, Mizuki N, et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 1997; 49: 448-454.
53. Vitiani LR, Potolicchio I, D'Amato M, Baricordi OR, Sorrentino R. MICA exon 5 microsatellite typing by DNA heteroduplex analysis: a new polymorphism in the transmembrane region. Tissue Antigens 1998; 51: 309-311.
54. Mizuki N, Ota M, Kimura M, et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci USA 1997; 94: 1298-1303.
55. Kawabata Y, Ikegami H, Kawaguchi Y, et al. Age-related association of MHC class I chain-related gene A (MICA) with type 1 (insulin-dependent) diabetes mellitus. Hum Immunol 2000; 61: 624-629.
56. Park Y, Lee H, Sanjeevi CB, Eisenbarth GS. MICA polymorphism is associated with type 1 diabetes in the Korean population. Diabetes Care 2001; 24: 33-38.
57. Gambelunghe G, Ghaderi M, Tortoioli C, et al. Two distinct MICA gene markers discriminate major autoimmune diabetes types. J Clin Endocrinol Metab 2001; 86: 3754-3760.
58. Dupont S, Dina C, Hani EH, Froguel P. Absence of replication in the French population of the association between beta 2/NEUROD-A45T polymorphism and type 1 diabetes. Diabetes Metab 1999; 25: 516, 517.
59. Hansen L, Jensen JN, Urioste S, et al. Danish Study Group of Diabetes in Childhood, and the Danish IDDM Epidemiology and Genetics Group. NeuroD/BETA2 gene variability and diabetes: no associations to late- onset type 2 diabetes but an A45 allele may represent a susceptibility marker for type 1 diabetes among Danes. Diabetes 2000; 49: 876-878.
60. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823-825.
61. 3 prevents insulitis in NOD mice. Diabetes 1992; 41: 1491-1495.
62. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-287.
63. Carling T, Kindmark A, Hellman P, et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1995; 1: 1309-1311.
64. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population. J Clin Endocrinol Metab 2000; 85: 4639-4643.
65. Ban Y, Ban Y, Taniyama M, Katagiri T. Vitamin D receptor initiation codon polymorphism in Japanese patients with Graves' disease. Thyroid 2000; 10: 475-480.
66. Ban Y, Taniyama M, Ban Y. Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid 2001; 11: 607, 608.
67. Fukazawa T, Yabe I, Kikuchi S, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci 1999; 166: 47-52.
68. McDermott ME, Ramachandran A, Ogunkolade BW, et al. Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia 1997; 40: 971-975.
69. Pani MA, Knapp M, Donner H, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes 2000; 49: 504-507.
70. Pennline KJ, Rogue-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin Immunol Immunopathol 1994; 71: 169-175.
71. Wogensen L, Lee M-S, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med 1994; 179: 1379-1384.
72. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
73. Foulis AK, Clark A Pathology of the pancreas in diabetes mellitus. In Joslin's Diabetes Mellitus, Kahn CR, Weir GC (eds). Lea & Febiger: Philadelphia, PA, 1994; 265-281.
74. Itoh N, Hanafusa T, Miyazaki A, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993; 92: 2313-2322.
75. Shimada A, Imazu Y, Morinaga S, et al. T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report. Diabetes Care 1999; 22: 615-617.
76. Leslie RD, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes. Diabetologia 1999; 42: 3-14.
77. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933.
78. Sera Y, Kawasaki E, Abiru N, et al. Autoantibodies to multiple islet autoantigens in patients with abrupt onset type 1 diabetes and diabetes diagnosed with urinary glucose screening. J Autoimmun 1999; 13: 257-265.
79. Sabbah E, Savola K, Kulmala P, et al. The Childhood Diabetes in Finland Study Group. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). Clin Exp Immunol 1999; 116: 78-83.
80. Feeney SJ, Myers MA, Mackay IR, et al. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM. Diabetes Care 1997; 20: 1403-1407.
81. Urakami T, Miyamoto Y, Fujita H, Kitagawa T. Type I (insulin-dependent) diabetes in Japanese children is not a uniform disease. Diabetologia 1989; 32: 312-315.
82. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence. Ann Med 2000; 32: 539-543.
83. Bonifacio E, Lampasona V, Bingley PJ. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens. J Immunol 1998; 161: 2648-2654.
84. Kawasaki E, Yu L, Gianani R, et al. Evaluation of islet cell antigen (ICA) 512/IA-2 autoantibody radioassays using overlapping ICA512/IA-2 constructs. J Clin Endocrinol Metab 1997; 82: 375-380.
85. Zhang B, Lan MS, Notkins AL. Autoantibodies to IA-2 in IDDM: location of major antigenic determinants. Diabetes 1997; 46: 40-43.
86. Savola K, Bonifacio E, Sabbah E, et al. The Childhood Diabetes in Finland Study Group. IA-2 antibodies - a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 1998; 41: 424-429.
87. Genovese S, Bonfanti R, Bazzigaluppi E, et al. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Diabetologia 1996; 39: 1223-1226.
88. Kawasaki E, Sera Y, Fujita N, et al. Association between IA-2 autoantibody epitope specificities and age of onset in Japanese patients with autoimmune diabetes. J Autoimmun 2001; 17: 323-331.
89. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K. Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes. Diabetes 1987; 36: 510-517.
90. Kawasaki E, Yamaguchi Y, Nagataki S. Insulitis in an autoimmune-mediated patient originally classified as having type 2 diabetes. Diabetes Care 1999; 22: 541, 542.
91. Kasuga A, Maruyama T, Nakamoto S, Ozawa Y, Suzuki Y, Saruta T. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients. J Autoimmun 1999; 12: 131-135.
92. Kobayashi T, Nakanishi K, Murase T, Kosaka K. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive β-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 1996; 45: 622-626.
93. Takino H, Yamasaki H, Abiru N, et al. Antibodies to GAD in initially diagnosed with type 2 diabetes. High titer of GAD Ab is a predictive marker for early insulin treatment. Diabet Med 2002; in press.